In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Bristol Myers Squibb (BMS) has shared promising results from a late-stage study of its dual immunotherapy combination in ...

AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the US Food and Drug ...

We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending ...

Roche and Sarepta Therapeutics have shared positive top-line results from a late-stage study of Elevidys (delandistrogene ...

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of ...